DiaGenic ASA: Notification of Trade Among Primary Insiders
OSLO, Norway--(BUSINESS WIRE)--Regulatory News: Reference is made to the stock exchange announcement from DiaGenic ASA (“DiaGenic” or the Company”)(OSE:DIAG) on 8 March 2013 regarding the conducted private placement in which the Company’s management and members of the board of directors have subscribed and been allocated shares at a subscription price of NOK 0.60 per share. The primary insiders have been allocated a total of 825,000 shares at NOK 0.60 per share. The transactions are described in more detail below. Henrik Lund, Chairman of the Board of DiaGenic, was allotted 83,333 shares in the private placement. After the completion of the private placement Lund will increase his holding in the Company from 40,000 shares to 123,333 shares.